Bioventus (BVS) Raw Materials (2020 - 2026)

Bioventus (BVS) has reported Raw Materials for 7 consecutive years, with $18.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Raw Materials fell 21.65% year-over-year to $18.4 million; the trailing twelve-month figure through Jun 2026 stood at $18.4 million (down 21.65% YoY), and the FY2025 full-year result was $21.2 million, down 3.88% from the prior year.
• Raw Materials declined to $18.4 million in Q2 2026 per BVS's latest filing, from $19.3 million in the prior quarter.
• Across five years, Raw Materials topped out at $26.4 million in Q3 2023 and bottomed at $14.3 million in Q2 2022.
• Historically, Raw Materials has averaged $21.6 million across 5 years, with a median of $22.0 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Raw Materials jumped 414.05% in 2022, then retreated 21.65% in 2026.
• Over 5 years, Raw Materials stood at $18.5 million in 2022, then rose by 14.13% to $21.1 million in 2023, then advanced by 4.92% to $22.1 million in 2024, then decreased by 3.88% to $21.2 million in 2025, then slipped by 13.55% to $18.4 million in 2026.
• According to Business Quant data, Raw Materials over the past three periods registered $18.4 million, $19.3 million, and $21.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.